Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-29 16:21:01 - browse：2365

Palm Drive at Stanford University on March 28, 2023 — Palm Drive at the entrance to Stanford University. Brian Frank for STAT

The resignation of Marc Tessier-Lavigne as president of Stanford University following an investigation into irregularities in his past research marks more than just the startling downfall of the leader of one of the nation’s top research powerhouses. The case is likely to have broader repercussions, signaling a tipping point in an ongoing and often contentious debate about how to assign blame and credit in the increasingly collaborative world of research.

Science is a team sport. And while the lab leaders, or principal investigators, often get most of the attention for biomedical breakthroughs, they seldom run experiments. That work is left to postdoctoral researchers, graduate students, and others who peer through microscopes, labor away in mouse rooms, and spend countless hours pipetting. Instead, professors play more of a managerial role, supervising, critiquing, and offering big-picture feedback on the work that goes on in their lab.

It’s a longstanding arrangement, but one that leads to a thorny question when research is challenged: Who’s to blame? STAT put that question to Stanford faculty and students while reporting earlier this year on allegations of image manipulation and other misconduct related to research in Tessier-Lavigne’s lab, as well as researchers at other institutions. The answer varied depending on whom you asked.

Graduate students stressed that since faculty have no qualms using work done in their labs to land grants, win prizes, and build prestige, they should ultimately be accountable for problems with the science done under their supervision. Faculty generally agree, at least in principle, but are often quick to say that there are limits to how closely they can scrutinize their lab’s work, and that team science is in part based on trust. It’s an argument Tessier-Lavigne cited in his own statement about his resignation.

It’s also one he said wasn’t good enough.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Commercial surrogacy can be ethical, despite pope’s claims

WSS

UnitedHealth financials solid despite Change Healthcare cyberattack

General Catalyst, Summa Health deal will turn on physician buy

Why rehabilitation engineers need to center patients in their research

New Ultima Genomics DNA sequencer can read genome for $100

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Do digital therapeutics have a future in medicine?

Wikipedia

Wikipedia

Wikipedia

Hepatitis C has a cure — but many Americans still lack access to it

Biden administration opens offers in Medicare drug price negotiations

Apple is now the first public company to be valued at $3 trillion

Congressmen charge Covid hearing ‘could have been an email’

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

General Catalyst, Summa Health deal will turn on physician buy

Guidelines to prevent youth baseball injuries need more muscle

Do digital therapeutics have a future in medicine?

Hollywood unions extend contract negotiations for actors

After traumatic brain injury, life support decisions can use more time

hotspot

MassMutual is introducing free genetic testing for members

Cue Health's Covid

Novo Nordisk to expand supply of Wegovy for U.S. patients

Medicare drug price negotiation’s day in court

Diversity in clinical trials starts with building trust, experts say

Do digital therapeutics have a future in medicine?

entertainment

focus

Wikipedia

focus